Robert Ball
Chief Executive Officer @ Shoulder Innovations
Grand Rapids, United States
Robert Ball is a venture - series unknown investor at Shoulder Innovations in Grand Rapids focused on Medical and Biotechnology. Robert Ball is based out of Grand Rapids, Michigan, and is the Chief Executive Officer and Executive Chairman of the Board at Shoulder Innovations. Robert previously worked at Embody as a Board of Director. Robert Ball attended Kettering University.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Robert Ball invests in
Stages Robert Ball invests in
Countries Robert Ball invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Biotechnology 1 (100%)
- Manufacturing 1 (100%)
- Medical Device 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Embody Inc is a regenerative medicine company that focuses on the development and commercialization of implantable medical devices to address the unmet demands in soft tissue restoration and regeneration. The company specializes in biomaterial design, bio-fabrication, nanotechnology, and medical devices.It was founded in 2015 and headquartered inNorfolk, Virginia. | $3.6M / Venture - Series Unknown / Mar 08, 2019 |
Co-Investors
About Shoulder Innovations
Shoulder Innovations is a medical device company that has developed inset glenoid fixation technology, creating the most robust and stable glenoid platform in the industry. The company's Total Shoulder Replacement System addresses the most significant issue in shoulder arthroplasty: unreliable fixation of the glenoid implant. It also leveragesthis technology to create simple surgical instrumentation, which reduces operative time and cost.Shoulder Innovations designs and commercializes innovative products that demonstrate the potential for improved patient care and reduced overall cost to the healthcare system. Published results show Shoulder Innovations’ solution provides greater post-surgical implant stability, addressing the leading cause of revision surgery.
Shoulder Innovations Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Robert Ball
Chief Executive Officer
|
|||
|
Jeff Ondria
CTO
|
|||
|
Matt Ahearn
COO
|
|||
|
Stephen B. Gunther
founder & Director
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Robert Ball invest in?
Robert Ball invests primarily in Medical, Biotechnology and Manufacturing startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Robert Ball?
Public channels for Robert Ball include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Robert Ball last invest?
The most recent investment recorded for Robert Ball closed in Mar 2019. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!